Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Mogamulizumab in Patients with Mycosis Fungoides/Sézary Syndrome: Preliminary Results from an Ongoing Phase 2, Open-Label, Multicenter, Single-Arm Study Assessing a 4-Weekly Dosing Schedule
Mogamulizumab in Patients with Mycosis Fungoides/Sézary Syndrome: Preliminary Results from an Ongoing Phase 2, Open-Label, Multicenter, Single-Arm Study Assessing a 4-Weekly Dosing Schedule Querfeld, C., Scarisbrick, J. J., Akilov, O., Arora, P., Liu, Y., Bagot, M., Cordoba, R., Cowan, R., Garcia-Sancho, A., Geskin, L. J., Huen, A. O., Jadwani, J., Morris, S., Ortiz-Romero, P. L., Patel, A., Pinter-Brown, L. C., Pujol, R. M., Quaglino, P., Saba, N. S., Vuppugalla, R., Zhao, H., Kim, Y. H. ELSEVIER. 2024: 3056-3058View details for DOI 10.1182/blood-2024-200596
View details for Web of Science ID 001412786000004